Trial drug can significantly block early stages of COVID-19 in engineered human tissues

Posted · Add Comment
scidaily-logo-rss

An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

This full article appears on <a href="https://www.sciencedaily.com/releases/2020/04/200402144526.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *